Skip to content

Ultrasound-guided erector spinal plane block combined with local infiltration anesthesia using bupivacaine liposomes in lumbar spine surgery: a randomized controlled clinical study

Ultrasound-guided erector spinal plane block combined with local infiltration anesthesia using bupivacaine liposomes in lumbar spine surgery: a randomized controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094415
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-12-27
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

erector spinal plane block group:Before operation, the patients were subjected to the descending vertical spinal muscle plane nerve block under ultrasound guidance. Local anesthetic ratio: Bupivacaine
Control group:Before operation, the patients underwent ultrasound-guided descending erector spinal muscle plane nerve block with 40ml normal saline. Local infiltration anesthesia was performed by the

Sponsors

Zhongshan Hospital(Xiamen), Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-85 years old; 2. Selected posterior median incision lumbar single or multiple level decompression through intervertebral foramina bone fusion internal fixation; 3. BMI 18-32; 4. Gender unlimited; 5. Volunteer to participate in this clinical study.

Exclusion criteria

Exclusion criteria: 1. Liver insufficiency; 2. Renal insufficiency; 3. Tuberculosis or tumor of the spine; 4. Diseases of the central nervous system, mental illness; 5. Spinal deformity or trauma; 6. Infection near the puncture site; 7. Insufficiency of blood coagulation; 8. Preoperative bradycardia with atrioventricular block (grade 2 or 3), long-term beta-blocker therapy, and ongoing QT interval prolongation medication; 9. Inability to cooperate and communicate with patients; 10. History of chronic pain, long history of alcohol use, and drug abuse; 11. Pregnant women; 12. Patients who refused pain relief pumps; 13. Patients who are allergic to the experimental drug.

Design outcomes

Primary

MeasureTime frame
Cumulative opioid consumption in 72 hours after surgery;

Secondary

MeasureTime frame
NRS scores at rest and exercise 2h, 6h, 12h, 24h, 48h, 72h after surgery;Quality of sleep on the night of surgery;24h, 48h and 72h recovery quality;The time of the first outbreak of pain, the clinician's remedies for pain: including the number of remedies, remedies and doses of remedies;The occurrence of anesthesia-related complications within 3 days after the operation, including: hypotension, hypertension, bradycardia, tachycardia, dizziness, urinary retention, pruritus, respiratory depression, cognitive dysfunction and delirium, as well as the handling situations of these complications.;The time when the patient first got out of bed for activities, the total length of hospital stay, the time when the drainage tube was removed, and the surgical complications;

Countries

China

Contacts

Public ContactZhiyao Wang

Zhongshan Hospital, Fudan University; Zhongshan Hospital(Xiamen), Fudan University

zhiyaowang_0313@163.com+86 150 2152 1161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026